2-37146107-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001135651.3(EIF2AK2):​c.240+746A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.844 in 152,052 control chromosomes in the GnomAD database, including 55,551 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.84 ( 55551 hom., cov: 30)

Consequence

EIF2AK2
NM_001135651.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.308

Publications

6 publications found
Variant links:
Genes affected
EIF2AK2 (HGNC:9437): (eukaryotic translation initiation factor 2 alpha kinase 2) The protein encoded by this gene is a serine/threonine protein kinase that is activated by autophosphorylation after binding to dsRNA. The activated form of the encoded protein can phosphorylate translation initiation factor EIF2S1, which in turn inhibits protein synthesis. This protein is also activated by manganese ions and heparin. The encoded protein plays an important role in the innate immune response against multiple DNA and RNA viruses. [provided by RefSeq, Jul 2021]
EIF2AK2 Gene-Disease associations (from GenCC):
  • leukoencephalopathy, developmental delay, and episodic neurologic regression syndrome
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Illumina, Labcorp Genetics (formerly Invitae), G2P
  • early-onset generalized limb-onset dystonia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • dystonia 33
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.975 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001135651.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EIF2AK2
NM_001135651.3
MANE Select
c.240+746A>G
intron
N/ANP_001129123.1P19525-1
EIF2AK2
NM_002759.4
c.240+746A>G
intron
N/ANP_002750.1P19525-1
EIF2AK2
NM_001135652.2
c.240+746A>G
intron
N/ANP_001129124.1P19525-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EIF2AK2
ENST00000233057.9
TSL:2 MANE Select
c.240+746A>G
intron
N/AENSP00000233057.4P19525-1
EIF2AK2
ENST00000405334.5
TSL:1
c.240+746A>G
intron
N/AENSP00000385014.1P19525-2
EIF2AK2
ENST00000395127.6
TSL:5
c.240+746A>G
intron
N/AENSP00000378559.2P19525-1

Frequencies

GnomAD3 genomes
AF:
0.844
AC:
128230
AN:
151934
Hom.:
55535
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.628
Gnomad AMI
AF:
0.911
Gnomad AMR
AF:
0.913
Gnomad ASJ
AF:
0.895
Gnomad EAS
AF:
0.998
Gnomad SAS
AF:
0.909
Gnomad FIN
AF:
0.944
Gnomad MID
AF:
0.892
Gnomad NFE
AF:
0.923
Gnomad OTH
AF:
0.868
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.844
AC:
128295
AN:
152052
Hom.:
55551
Cov.:
30
AF XY:
0.848
AC XY:
63072
AN XY:
74336
show subpopulations
African (AFR)
AF:
0.628
AC:
25990
AN:
41384
American (AMR)
AF:
0.913
AC:
13959
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.895
AC:
3109
AN:
3472
East Asian (EAS)
AF:
0.998
AC:
5164
AN:
5174
South Asian (SAS)
AF:
0.909
AC:
4386
AN:
4824
European-Finnish (FIN)
AF:
0.944
AC:
9995
AN:
10588
Middle Eastern (MID)
AF:
0.895
AC:
263
AN:
294
European-Non Finnish (NFE)
AF:
0.923
AC:
62764
AN:
68014
Other (OTH)
AF:
0.870
AC:
1834
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
875
1750
2625
3500
4375
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
880
1760
2640
3520
4400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.875
Hom.:
9869
Bravo
AF:
0.832
Asia WGS
AF:
0.939
AC:
3267
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
7.0
DANN
Benign
0.72
PhyloP100
0.31
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2373114; hg19: chr2-37373250; API